<?xml version="1.0" encoding="UTF-8"?>
<ref id="B140-nanomaterials-10-01072">
 <label>140.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Maurer</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Jennings</surname>
    <given-names>G.T.</given-names>
   </name>
   <name>
    <surname>Willers</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Rohner</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Lindman</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Roubicek</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Renner</surname>
    <given-names>W.A.</given-names>
   </name>
   <name>
    <surname>MÃ¼ller</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Bachmann</surname>
    <given-names>M.F.</given-names>
   </name>
  </person-group>
  <article-title>A therapeutic vaccine for nicotine dependence: Preclinical efficacy, and Phase I safety and immunogenicity</article-title>
  <source>Eur. J. Immunol.</source>
  <year>2005</year>
  <volume>35</volume>
  <fpage>2031</fpage>
  <lpage>2040</lpage>
  <pub-id pub-id-type="doi">10.1002/eji.200526285</pub-id>
  <pub-id pub-id-type="pmid">15971275</pub-id>
 </element-citation>
</ref>
